Related Experiment Videos
CD44 isoforms in prognosis of breast cancer
Lancet (London, England)
|August 19, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy⋆.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Renal Tubular Dysgenesis in a Case of Fetus Acardius Amorphus.
Case reports in pathology·2019
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care.
Lancet (London, England)·2026
Adverse pregnancy outcomes and long-term cardiovascular disease risk.
Lancet (London, England)·2026
DLST Succinylation-Mediated Mitochondrial Metabolic Remodeling and Cuproptosis Resistance Promote Malignant Progression of Lung Adenocarcinoma.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026